Biodistribution and function of coupled polymer-DNA origami nanostructures

Area of Science:

• Biotechnology
• Nanomedicine
• Materials Science

Background:

• Precise spatial control of therapeutics is crucial for minimizing side effects.
• Current drug delivery systems often lack sophisticated control over distribution.
• Novel nanostructures offer potential for enhanced therapeutic targeting and efficacy.

Purpose of the Study:

• To develop and characterize a polymer-DNA hybrid nanostructure for controlled therapeutic distribution.
• To assess the in-vivo stability and diffusion properties of the nanostructure.
• To evaluate the therapeutic potential of the nanostructure in an inflammatory model.

Main Methods:

• Fabrication of coupled polymer-DNA origami hybrid nanostructures.
• Assessment of serum stability and tissue diffusion properties.
• In-vivo evaluation in a delayed-type hypersensitivity model using aptamer-functionalized agents.

Main Results:

• The nanostructures demonstrated high stability in serum and slow diffusion, influenced by shape and aspect ratio.
• Polyethylene glycol (PEG) coupling via polyamine electrostatic interactions enhanced in-vivo stability (>90% integrity after 5 days).
• Aptamer-functionalized agents significantly abrogated inflammatory responses in a humanized tumor necrosis factor (TNF-alpha) mouse model.

Conclusions:

• Polymer-DNA hybrid nanostructures represent a programmable and pharmacologically viable platform for drug delivery.
• These agents offer enhanced control over the spatial dimension of drug activity.
• This technology presents a promising alternative to conventional therapeutics like monoclonal antibodies.